Next Article in Journal
Corporate Bankruptcy Prediction Model, a Special Focus on Listed Companies in Kenya
Next Article in Special Issue
Suspending Classes Without Stopping Learning: China’s Education Emergency Management Policy in the COVID-19 Outbreak
Previous Article in Journal
A General Family of Autoregressive Conditional Duration Models Applied to High-Frequency Financial Data
Previous Article in Special Issue
Risk Management of COVID-19 by Universities in China
Open AccessEditorial

Prevention Is Better Than the Cure: Risk Management of COVID-19

by Michael McAleer 1,2,3,4,5
Department of Finance, Asia University, Taichung 41354, Taiwan
Discipline of Business Analytics, University of Sydney Business School, Sydney 2006, Australia
Econometric Institute, Erasmus School of Economics, Erasmus University Rotterdam, 3062 Rotterdam, The Netherlands
Department of Economic Analysis and ICAE, Complutense University of Madrid, 28040 Madrid, Spain
Institute of Advanced Sciences, Yokohama National University, Yokohama 240-8501, Japan
J. Risk Financial Manag. 2020, 13(3), 46;
Received: 28 February 2020 / Accepted: 28 February 2020 / Published: 3 March 2020
(This article belongs to the Special Issue COVID-19’s Risk Management and Its Impact on the Economy)
A novel coronavirus was reported to the World Health Organization (WHO) in China on 31 December 2019. The WHO named the disease COVID-19 on 11 February 2020. As of 26 February 2020, the disease has been detected on all continents, except for Antarctica. Daily updates on COVID-19 since early February 2020 have made headline news worldwide for much of 2020. This editorial evaluates risk management based on the Global Health Security (GHS) Index of global health security capabilities in 195 countries. The GHS Index lists the countries best prepared for an epidemic or pandemic. COVID-19 is compared with two related coronavirus epidemics, SARS and MERS, in terms of the number of reported human infections, deaths, countries, major country clusters, timelines, and the likelihood of discovering a safe, effective, and approved vaccine. View Full-Text
Keywords: COVID-19; SARS; MERS; risk management; vaccines; cures; clinical trials COVID-19; SARS; MERS; risk management; vaccines; cures; clinical trials
MDPI and ACS Style

McAleer, M. Prevention Is Better Than the Cure: Risk Management of COVID-19. J. Risk Financial Manag. 2020, 13, 46.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop